Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap3.47B
Enterprise Value3.60B
ADPT
(NASDAQ)Adaptive Biotechnologies Corporation
$22.31-- (--)
Loading... - Market loading
Adaptive Biotechnologies (ADPT) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)11.75
Forward Price/Sales7.54
Price/Book (mrq)16.04
Price/Tangible Book (mrq)36.12
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue12.19
EV/Earnings-72.47
EV/EBITDA-135.10
EV/EBIT-71.90
EV/FCF-121.90
Stock Price
Current price, 52-week range, and moving averages
Current Price$22.31
1-Day Change1.64%
52-Week High$23.15
52-Week Low$9.96
52-Week Change105.24%
YTD Change40.23%
1-Year Change109.29%
50-Day MA$18.04
200-Day MA$16.36
Avg Volume (30 day)3.64M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding155.52M
Book Value per Share$1.39
Net Cash per Share$-0.84
FCF per Share$-0.19
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$20.67
Target Upside/Downside-7.35%
Analyst ConsensusBuy
Analyst Count9
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin75.26%
EBITDA Margin (ttm)-9.02%
EBIT Margin (ttm)-16.95%
Operating Margin (ttm)-15.82%
Pretax Margin (ttm)-16.81%
Profit Margin (ttm)-16.82%
FCF Margin (ttm)-10.00%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-22.96%
Return on Assets (ttm)-9.82%
Return on Invested Capital (ttm)-11.40%
Return on Capital Employed (ttm)-11.95%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue295.41M
Gross Profit222.32M
Operating Income-46.73M
Pretax Income-49.66M
Net Income-49.68M
EBITDA-26.65M
EBIT-50.07M
Diluted EPS$-0.32
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-27.04M
Capital Expenditures2.50M
Free Cash Flow-29.54M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth55.87%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)505.94M
Cash & Securities (mrq)77.58M
Net Cash (mrq)-130.60M
Net Cash per Share$-0.84
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)208.18M
Working Capital (mrq)204.80M
Total Equity (mrq)216.34M
Book Value per Share$1.39
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)3.35
Quick Ratio (mrq)3.22
Debt/Equity (mrq)0.96
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-1.43%
FCF Yield-0.85%
Buyback Yield-0.94%
Total Shareholder Yield-0.94%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-6.12
Piotroski F-Score5/9
Frequently Asked Questions About Adaptive Biotechnologies Statistics
What are the key financial metrics for ADPT?
Adaptive Biotechnologies Corporation (ADPT) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is ADPT's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Adaptive Biotechnologies is overvalued or undervalued.
How do I read ADPT's profitability ratios?
Adaptive Biotechnologies's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do ADPT's debt ratios indicate?
The financial health section shows Adaptive Biotechnologies's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is ADPT's dividend analysis?
The dividend section covers Adaptive Biotechnologies's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.